Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background/aim: The inhibition of differentiation in myeloid progenitor cells is a hallmark of acute myeloid leukemia (AML). The chemotherapy regimen for AML patients, the so-called 7+3 protocol and the survival rate, have remained unchanged for decades, leaving AML one of the most lethal diseases among adults. Differentiation therapy represents a promising approach that aims to induce the maturation of leukemic progenitor cells into non-proliferative, terminally differentiated cells, thereby directly targeting the underlying pathogenesis of the disease.
Materials And Methods: The anti-leukemic effects of protopine were evaluated using flow cytometry, MTS assay, cell proliferation assay, and trypan blue exclusion test. Mitochondrial reactive oxygen species (ROS) levels were assessed using MitoSOX Red staining. Apoptosis- and cell survival-related proteins were analyzed via Western blotting. Disruption of mitochondrial membrane potential was determined using the JC-1 dye.
Results: Protopine exhibited differentiation-inducing activity in AML cells, which was closely associated with its inhibitory effects on cell proliferation and viability. Mechanistically, increased ROS levels and subsequent up-regulation of cyclin-dependent kinase inhibitors p16 and p21 played a critical role in protopine-induced differentiation. Additionally, protopine suppressed the AKT and ERK survival signaling pathways and down-regulated anti-apoptotic Bcl-2 family proteins. These changes were associated with mitochondrial membrane potential disruption and the induction of apoptosis.
Conclusion: Protopine represents a promising candidate for differentiation-based therapy in AML.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.21873/anticanres.17730 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diosgenin-loaded Silver Nanoparticles: Dual Protective Role and Enhanced Radiosensitivity against ENU-induced Leukemia and γ-irradiation-induced Liver Toxicity.
Recent Pat Anticancer Drug Discov
September 2025
Department of Biophysics, Faculty of Applied Health Sciences, October 6 University, Egypt.
Introduction: Leukemia and radiation-induced liver toxicity are significant health challenges requiring effective therapeutic strategies. This study aimed to evaluate the therapeutic efficacy and radiosensitizing effects of Diosgenin-loaded silver nanoparticles (Dio-AgNPs) in ENU-induced leukemic mice, with a focus on their dual role in mitigating leukemia progression and γ-irradiation-induced hepatotoxicity.
Methods: Dio-AgNPs were synthesized and characterized using TEM, UV-Vis spectroscopy, FT-IR spectroscopy, and encapsulation efficiency analysis.
Unlabelled: Patients with myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) with high-risk features including mutations and deletions have poor outcomes due to lack of effective therapies. The atypical chemokine surface receptor C-C motif chemokine receptor-like 2 (CCRL2) is overexpressed in MDS and secondary AML (sAML) compared to healthy hematopoietic cells and we recently found that -mutated MDS/AML and AML with erythroid features express the highest levels of this receptor across MDS/AML subtypes. To illustrate the therapeutic potential of CCRL2 as a therapeutic target, we developed an anti-CCRL2 antibody-drug conjugate (ADC) by conjugating an anti-CCRL2 antibody with the cytotoxic drug pyrrolobenzodiazepine (PBD), which causes DNA double-strand breaks leading to cancer cell death.
View Article and Find Full Text PDFProtopine Exerts Anti-Leukemic Effects by Promoting ROS-mediated Inhibition of Survival Signals in Acute Myeloid Leukemia Cells.
Anticancer Res
September 2025
Department of Integrated Biological science, Pusan National University, Busan, Republic of Korea;
Background/aim: The inhibition of differentiation in myeloid progenitor cells is a hallmark of acute myeloid leukemia (AML). The chemotherapy regimen for AML patients, the so-called 7+3 protocol and the survival rate, have remained unchanged for decades, leaving AML one of the most lethal diseases among adults. Differentiation therapy represents a promising approach that aims to induce the maturation of leukemic progenitor cells into non-proliferative, terminally differentiated cells, thereby directly targeting the underlying pathogenesis of the disease.
View Article and Find Full Text PDFThe bispecific innate cell engager AFM28 eliminates CD123 leukemic stem and progenitor cells in AML and MDS.
Nat Commun
August 2025
Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Strategies targeting leukemic stem and progenitor cells (LSPCs) are needed for durable remissions in acute myeloid leukemia (AML) and high-risk myelodysplastic neoplasms (MDS). While CD123 constitutes a promising target on LSPCs and leukemic blasts, previous CD123-targeting approaches showed limited efficacy and challenging safety profiles. Here, we describe the preclinical efficacy and safety of the bispecific CD123/CD16A innate cell engager "AFM28", demonstrating superior activity against AML and MDS patient-derived LSPCs and blasts in vitro compared to an Fc-enhanced CD123-targeting antibody, especially towards CD123 and/or CD64 leukemic cells.
View Article and Find Full Text PDFTLR2 Agonism Suppresses Myeloid Leukemogenesis by Reprogramming Leukemia Stem Cells.
Blood Adv
August 2025
Thomas Jefferson University, Philadelphia, Pennsylvania, United States.
The consequences of activated innate immune signaling in acute myeloid leukemia (AML) is not well understood. Using ligands directed at the Toll-like family receptors (TLR) in models of high-risk AML, we uncover that TLR2 ligands exert unique anti-leukemic effects that are distinct from other TLRs. While TLR2 signaling broadly induces inflammatory gene expression in AML cells, at the single cell level, cell-type-dependent, divergent transcriptional responses coordinate cellular outputs of proliferation, differentiation, cell death, and activation of immune cell function.
View Article and Find Full Text PDF